The cure rate of breast cancer is based on the five-year survival rate, and the five-year survival rate of ductal carcinoma in situ of the breast is about 98.8%.
Breast cancer is a malignant neoplastic lesion originating from the epithelial cells of the breast, and the cause of its occurrence is related to genetic factors, mental factors, long-term exposure to radioactive or toxic substances, and daily life and dietary habits, etc. It is mainly divided into non-invasive breast cancer and invasive breast cancer. It is mainly categorized into non-invasive breast cancer and invasive breast cancer, among which, non-invasive breast cancer is further categorized into ductal carcinoma in situ and other lesions.
Ductal carcinoma in situ is an early stage of the disease process. If the lesion can be diagnosed and actively treated, the diseased tissue will be removed, and then according to the results of pathological type, immunohistochemistry and gene test after the operation, follow-up endocrine therapy and targeted drug therapy will be carried out to consolidate the effect of the operation as much as possible. The patient’s five-year survival rate after surgery was about 98.8%.
Although the patient’s cure rate is very high, it is important to be vigilant after the surgery and pay attention to regular medical checkups to monitor the patient’s postoperative recovery. If the patient shows signs of recurrence, he or she must actively participate in the treatment to try to stabilize the condition and prolong the patient’s survival time.